Furthermore, the RFS was significantly worse in patients with larger tumors with a diameter of over >40 mm, those with ≥pT stage 3, those with Fuhrman grade ≥III, and those with ND1 mutations in RCC specimens. This evidence concerns the gene MT-ND1 and renal cell carcinoma.